Pradžia › Ambliopija › Texas
Ambliopija klinikiniai tyrimai Texas
8 tyrimai dėl Ambliopija ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
Video Treatment for Amblyopia
- Retina Foundation, Dallas
Renkami dalyviai
Amžius nuo 3 iki 7 · Visoms lytims · Atnaujinta 2026-04-07 · NCT05439200Binocular Amblyopia Treatment
- Retina Foundation of the Southwest, Dallas
Renkami dalyviai
Amžius nuo 4 iki 10 · Visoms lytims · Atnaujinta 2026-02-23 · NCT03288948Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- Texas Children's Hospital - Dept. Of Ophthalmology, Houston
- Texas Tech University Health Science Center, Lubbock
- University of the Incarnate Word, San Antonio
Renkami dalyviai3 fazė
Amžius nuo 4 iki 7 · Visoms lytims · Atnaujinta 2026-02-11 · NCT06380517Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
- Baylor College of Medicine, Houston
- University of Houston - College of Optometry, Houston
- University of Houston College of Optometry, Houston
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 8 iki 12 · Visoms lytims · Atnaujinta 2026-02-11 · NCT06524882A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- Pediatric Eye Specialists, LLP, Fort Worth
- Baylor College of Medicine, Houston
- Texas Tech University Health Science Center, Lubbock
- ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 3 iki 13 · Visoms lytims · Atnaujinta 2026-02-11 · NCT04378790Patch-free Occlusion Therapy
- Retina Foundation, Dallas
Renkami dalyviai
Amžius nuo 3 iki 12 · Visoms lytims · Atnaujinta 2026-01-07 · NCT05440448Amblyopia Treatment for Children Aged 8 to 12 Years
- Retina Foundation of the Southwest, Dallas
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 8 iki 12 · Visoms lytims · Atnaujinta 2025-12-15 · NCT07281742Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
- Pediatric Eye Specialist, Fort Worth
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2025-09-12 · NCT06429280Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.